Showing 20 of 112 recruiting trials for “Adult hepatocellular carcinoma”
Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)
RecruitingNCT05705219 ↗
Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients
👨⚕️ Ahmed El Kaffas, PhD, University of California, San Diego📍 3 sites📅 Started Dec 2023View details ↗
Phase 2 Study of ADI-PEG 20 Plus Lenvatinib Treatment in Subjects With Unresectable Hepatocellular Carcinoma
RecruitingNCT06117891 ↗
An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With Surgery
Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular Carcinoma
Durvalumab and Tremelimumab in Resectable HCC
RecruitingNCT05263830 ↗
Glypican-3 as a Prognostic Factor in Patients With Hepatocellular Carcinoma Treated by Immunotherapy
👨⚕️ Manon ALLAIRE, Dr, Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Sep 2023View details ↗
RecruitingNCT06060769 ↗
Study on the Quantitative Assessment of the Risk of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Using Multi-parameter Magnetic Resonance Imaging
👨⚕️ Yaqin Zhang, MD, Ph.D, Fifth Affiliated Hospital, Sun Yat-Sen University📍 1 site📅 Started Sep 2023View details ↗
RecruitingNCT06036563 ↗
Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing
Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.
Serplulimab Combined With Bevacizumab Biosimilar and HAIC in Advanced Hepatocellular Carcinoma (HCC) Patients
Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials
AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease
👨⚕️ Anthony B El-Khoueiry, MD, University of Southern California📍 2 sites📅 Started Mar 2023View details ↗
Immunotherapy and Radioembolisation for Metastatic Hepatocellular Carcinoma
A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative Resection
RecruitingNCT06806579 ↗
Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma
👨⚕️ Francesco Tovoli, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 24 sites📅 Started Dec 2022View details ↗
Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC
the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma
👨⚕️ Cai Jian qiang, Cancer Institute and Hospital, Chinese Academy of Medical Sciences📍 5 sites📅 Started Nov 2022View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →